IGF-1 LR3: status and safety
Medically reviewed by the Rite Aid Health Team · Last updated July 9, 2026
Banned in competitive sport. This peptide is prohibited by the World Anti-Doping Agency (WADA), and athletes subject to drug testing can face sanctions for using it. Check current WADA and league rules before considering it.
Long-acting modified IGF-1 analog used in research. It is prohibited in competitive sport.
Check what the compound is, whether it has an FDA-approved use, and which safety or sports-rule issues matter. This is not a recommendation, protocol, stack suggestion, or buying guide.
Almost done
We sent the first email to .
Confirm your email to secure 20% off your first compounded-peptide order. We'll notify you when consultations and ordering open.
-
1
Confirm your email
Open the first email and click the confirmation link.
-
2
Only after step 1
Your discount is locked in
Once you confirm, your discount is reserved. We will notify you when peptide services launch.
The first email should arrive within a minute. Do not see it? Check spam or promotions.
Get 20% off your first compounded-peptide order
Join the early-access waitlist and we'll notify you the moment consultations and ordering open.
What it is
- IGF-1 LR3 is engineered to reduce binding-protein interaction and extend activity compared with native IGF-1.
- It is marketed for growth and body-composition claims despite limited legitimate clinical use.
- It is distinct from approved recombinant IGF-1 replacement therapy.
For comparison, mecasermin (Increlex) is the FDA-approved recombinant human IGF-1 product used for severe primary IGF-1 deficiency. IGF-1 LR3 is a modified research analog and should not be treated as interchangeable with that approved medication.
Safety and evidence
Potential concerns include hypoglycemia, abnormal tissue growth signals, edema, and unknown cancer-related risk in unsupervised use.
For research-only compounds, the key issue is not just whether a mechanism sounds plausible. Identity, purity, sterility, dose accuracy, route, and human safety data all matter, and vendor vials are not equivalent to FDA-approved medications.
Regulatory status
Not FDA-approved. Banned in sport; research-only products are not approved for human use.
If a compound has an FDA-approved product or a legitimate clinical-trial pathway, that status applies to that regulated product or study. It does not validate research-only products sold for self-use. Research-only products are not approved for human use.
Almost done
We sent the first email to .
Confirm your email to secure 20% off your first compounded-peptide order. We'll notify you when consultations and ordering open.
-
1
Confirm your email
Open the first email and click the confirmation link.
-
2
Only after step 1
Your discount is locked in
Once you confirm, your discount is reserved. We will notify you when peptide services launch.
The first email should arrive within a minute. Do not see it? Check spam or promotions.
Get 20% off your first compounded-peptide order
Join the early-access waitlist and we'll notify you the moment consultations and ordering open.
Sources to check
For general education only — not medical advice or a treatment recommendation. Peptides are not a substitute for care from a licensed provider. Talk to a qualified healthcare professional before you start, stop, or change any peptide, medication, or supplement.
FAQ
No. It is not FDA-approved as a peptide therapy. Products sold for research use are not approved for human use.
No. Rite Aid does not recommend dosing, stacking, or self-experimentation.